HARBORNE MEDICAL PRACTICE
4 YORK STREET, HARBORNE, BIRMINGHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 18 | 19 | 94.7% | |
| HF 4 | 2011 | 17 | 22 | 77.3% | |
| HF 4 | 2012 | 18 | 22 | 81.8% | |
| HF 4 | 2013 | 15 | 17 | 88.2% | |
| HF004 | 2014 | 12 | 15 | 80.0% | |
| HF004 | 2015 | 8 | 11 | 72.7% | |
| HF004 | 2016 | 8 | 10 | 80.0% | |
| HF004 | 2017 | 8 | 11 | 72.7% | |
| HF004 | 2018 | 9 | 12 | 75.0% | |
| HF004 | 2019 | 11 | 13 | 84.6% | |
| HF004 | 2020 | 13 | 13 | 100.0% | |
| HF006 | 2021 | 37 | 59 | 62.7% | |
| HF006 | 2022 | 31 | 32 | 96.9% | |
| HF006 | 2023 | 28 | 30 | 93.3% |
